Can cannabis provide an alternative to opioid painkillers in the UK?
The past few years have seen a rise in the use of opioids as pain killers, but these medicines are highly addictive. Medical cannabis...
How you can help reduce financial barriers to medical cannabis access
For Medical Cannabis Awareness Week, which took place November 1 – 8, Sapphire Medical Foundation is looking to raise much-needed funds to help reduce...
FDA: cannabis, COVID-19 and misinformation
The US FDA’s Center for Drug Evaluation and Research tells us about the hazards of untested and unapproved cannabis treatments.
The US Center for Drug...
Calls for UK Government to deliver on medical cannabis commitment
Families of children with severe epilepsy and charities are pleading with the UK government to act on its promises for easier access to cannabis-based...
Medical Cannabis Awareness Week: calls for NHS prescriptions
Medical Cannabis Awareness Week is taking place from 1 – 8 November 2020. It brings together patients, doctors, sector organisations, supporters, and advocates to...
How can medical cannabis help the UK’s chronic pain problem?
In this article Dean Billington, Chief Operating Officer at Brains Bioceutical, discusses how medical cannabis can help the UK's chronic pain problem.
Chronic pain is...
CBD reduces COVID-19 lung damage with protective peptides
In a new study, scientists have shown that one of the non-psychoactive cannabinoids in cannabis – CBD – reduces lung damage induced by cytokine...
New UK medical cannabis products cheaper and safer than black market
Sapphire Medical Clinics are first to offer access to a new range of UK manufactured medical cannabis products which are now cheaper and safer...
Canadian legal medical cannabis system forcing patients to self-medicate
A new survey has demonstrated barriers in the legal medical cannabis system that are forcing patients to self-medicate without the support of a healthcare...
Medical Cannabis: life sciences and the law survey
Earlier this year life sciences law firm Hill Dickinson set out to discover the views of the UK public in regard to medical cannabis...
Addiction, education, and the future of cannabis policy
Cannabis specialist Dr Peter Grinspoon explores education and policy in US addiction treatment.
Dr Peter Grinspoon is a primary care physician, an instructor at Harvard...
Cannabis and hemp in the UK
Tim Henley, Director of the Cannabis Trades Association, speaks with MCN Quarterly about hemp and cannabis regulation, policy, and healthcare in the UK.
The Cannabis...
Cannabis and chronic pain in Australia
Painaustralia tells MCN Quarterly about the use of cannabis to treat chronic pain.
Despite making up around 60% to 70% of the customer base for...
Cancard: giving patients and police peace of mind
Medical cannabis patient Carly Barton has been working to create the UK’s new medical cannabis card that will protect patients from prosecution and save...
Medical cannabis: science and risk-based methodology
Independent consultancy NNE and venture advisory firm Volvér showcase the significance of science and risk in devising a manufacturing facility.
How can cannabis producers bring...
A resource-efficient cannabis industry starts with benchmarking
Resource Innovation Institute Executive Director Derek Smith highlights the importance of tracking resource consumption in cannabis production.
As the global COVID-19 pandemic provides a window...
LeafCann secures cannabis import licence from Australian Government
Privately-owned medicinal cannabis company LeafCann has secured a Medicinal Cannabis import licence from the Australian Government.
The licence, which will enable LeafCann to supply Australian...
People of colour must be represented across the cannabis industry
There is a renewed reckoning about the exclusion of women and people of colour from power and resources worldwide.
The cannabis industry is no exception...
Cannabis cultivation research and data
The International Cannabis Cultivation Questionnaire aims to develop a better understanding of patterns in small-scale cannabis production.
The Global Cannabis Cultivation Research Consortium (GCCRC) is...
Cloud 9 Switzerland Group: nutraceuticals and pharmaceuticals
Life sciences company Cloud 9 Switzerland prioritises patient wellbeing, product quality and innovation in clinical practice.
Cloud 9 Switzerland is a life sciences company offering...
